BNP/CALL/PFIZER INC/40/0.1/20.12.24 Share Price

Warrant

DE000PE84FN1

Delayed Deutsche Boerse AG 01:20:26 21/06/2024 am IST
0.008 EUR +700.00% Intraday chart for BNP/CALL/PFIZER INC/40/0.1/20.12.24
Current month-33.33%
1 month-11.11%
Date Price Change
20/24/20 0.008 +700.00%
19/24/19 0.001 -83.33%
18/24/18 0.006 +20.00%
17/24/17 0.005 -28.57%
14/24/14 0.007 +16.67%

Delayed Quote Deutsche Boerse AG

Last update June 21, 2024 at 01:20 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE84FN
ISINDE000PE84FN1
Date issued 14/02/2023
Strike 40 $
Maturity 20/12/2024 (183 Days)
Parity 10 : 1
Emission price 0.74
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.8
Lowest since issue 0.001
Spread 0.083
Spread %91.21%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.74 USD
Average target price
31.92 USD
Spread / Average Target
+15.05%
Consensus